Amantadine in the treatment of Parkinson's disease and other movement disorders
The efficacy of amantadine in the symptomatic treatment of patients with Parkinson's
disease, discovered serendipitously more than 50 years ago, has stood the test of time and …
disease, discovered serendipitously more than 50 years ago, has stood the test of time and …
Levodopa-induced dyskinesia in Parkinson's disease: pathogenesis and emerging treatment strategies
The most commonly used treatment for Parkinson's disease (PD) is levodopa, prescribed in
conjunction with carbidopa. Virtually all patients with PD undergo dopamine replacement …
conjunction with carbidopa. Virtually all patients with PD undergo dopamine replacement …
[HTML][HTML] Parkinson's disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis
G DeMaagd, A Philip - Pharmacy and therapeutics, 2015 - ncbi.nlm.nih.gov
Parkinson’s Disease and Its Management - PMC Back to Top Skip to main content NIH NLM
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search …
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search …
Pharmacological treatment of Parkinson disease: a review
BS Connolly, AE Lang - Jama, 2014 - jamanetwork.com
Importance Parkinson disease is the second most common neurodegenerative disease
worldwide. Although no available therapies alter the underlying neurodegenerative process …
worldwide. Although no available therapies alter the underlying neurodegenerative process …
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Involuntary movements, or dyskinesia, represent a debilitating complication of levodopa (L-
dopa) therapy for Parkinson's disease (PD). L-dopa-induced dyskinesia (LID) are ultimately …
dopa) therapy for Parkinson's disease (PD). L-dopa-induced dyskinesia (LID) are ultimately …
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
The objective was to update previous evidence‐based medicine reviews of treatments for
motor symptoms of Parkinson's disease published between 2002 and 2005. Level I …
motor symptoms of Parkinson's disease published between 2002 and 2005. Level I …
Summary of the recommendations of the EFNS/MDS‐ES review on therapeutic management of P arkinson's disease
JJ Ferreira, R Katzenschlager… - European journal of …, 2013 - Wiley Online Library
Objective To summarize the 2010 EFNS/MDS‐ES evidence‐based treatment
recommendations for the management of P arkinson's disease (PD). This summary includes …
recommendations for the management of P arkinson's disease (PD). This summary includes …
Medical and surgical management of advanced Parkinson's disease
A Antonini, E Moro, C Godeiro… - Movement …, 2018 - Wiley Online Library
Advanced Parkinson's disease is characterized by the presence of motor fluctuations,
various degree of dyskinesia, and disability with functional impact on activities of daily living …
various degree of dyskinesia, and disability with functional impact on activities of daily living …
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap
P Calabresi, M Di Filippo, V Ghiglieri… - The Lancet …, 2010 - thelancet.com
Levodopa is the most effective drug for the treatment of Parkinson's disease. However, the
long-term use of this dopamine precursor is complicated by highly disabling fluctuations and …
long-term use of this dopamine precursor is complicated by highly disabling fluctuations and …
[HTML][HTML] Medical management and prevention of motor complications in Parkinson's disease
Levodopa is the most effective medication for the treatment of the motor symptoms of
Parkinson's disease. However, over time, the clinical response to levodopa becomes …
Parkinson's disease. However, over time, the clinical response to levodopa becomes …